Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 370Observational 67Expanded_access 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 14Colorectal Neoplasms 9Carcinoma, Hepatocellular 9Gastrointestinal Stromal Tumors 7Carcinoma, Non-Small-Cell Lung 7Stomach Neoplasms 6Ovarian Neoplasms 6Liver Neoplasms 6Cholangiocarcinoma 6Prostatic Neoplasms 5Breast Neoplasms 5Melanoma 4Sarcoma 3Head and Neck Neoplasms 3Gastrointestinal Neoplasms 3Colonic Neoplasms 3Carcinoma, Squamous Cell 3Neuroblastoma 2Neoplasms 2Hepatoblastoma 2Glioblastoma 2Esophageal Neoplasms 2Endometrial Neoplasms 2Carcinoma, Renal Cell 2Wounds and Injuries 1Wilms Tumor 1Uveal Melanoma 1Uterine Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1

Interventions

derazantinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Expanded_access × Biliary Tract Neoplasms × Gastrointestinal × Clear all
NCT04087876 2025-04-06

Expanded Access Use of Derazantinib for Advanced Intrahepatic Cholangiocarcinoma (iCCA) With FGFR Genomic Alterations

Basilea Pharmaceutica

No longer available
Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Liver Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡